Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Bkemv (eculizumab-aeeb), an Interchangeable Biosimilar to Soliris
Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat...
CG Pharmaceuticals Prepares to Showcase Its Ongoing Phase 2 Study for Ivaltinostat in Metastatic Pancreatic Ductal Adenocarcinoma
ORINDA, Calif., May 29, 2024. CG Pharmaceuticals, a company dedicated to advancing innovative therapies to improve the lives of patients with cancer, prepares...
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending
From 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to...
Changes in Gender Identity Not Tied to Depressive Symptoms in Youth
Changes in gender identity are not associated with changes in depressive symptoms over time among sexual and gender minority (SGM) youth, according to...
Cannabis Use in United States Has Mirrored Policy Changes
Long-term trends in cannabis use have mirrored policy, with state-level legalization resulting in an increase in use, according to research published online...
Pharmacological Treatment of ADHD May Cut Some Forms of Criminality
Pharmacological treatment may reduce some types of criminality among adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD),...
U.S. Girls Are Beginning Periods Earlier
U.S. girls are getting their periods at younger ages, a new study has found. Girls born between 2000 and 2005 started their periods at an average age...
AI Implant Allows Stroke Survivor to Communicate in Both Spanish, English
A bilingual brain implant has allowed a stroke survivor to communicate in both Spanish and English, scientists report. Turning to an AI method known as...
Bird Flu Spotted in Alpacas for First Time
Bird flu has been detected for the first time in alpacas, the U.S. Department of Agriculture (USDA) announced Tuesday. The animals that tested positive...
Could Tattoos Be Linked to Blood Cancer Risk?
Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma. The findings are early, however, and...
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome
MELBOURNE, Australia, May 27, 2024. Neuren Pharmaceuticals (ASX: NEU) today announced top-line results from its Phase 2 clinical trial of NNZ-2591...
Subtle Mental Declines Occur Before Older Folk Quit Driving
One of the toughest decisions seniors face is when to give up their keys and stop driving. Even slight changes to the ability to remember, think and reason...
Recently Added
Recently added consumer and prescribing information: Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Bkemv Bkemv (eculizumab-aeeb) is a complement inhibitor interchangeable biosimilar to Soliris for the treatment of paroxysmal nocturnal...
- Yesafili Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
- Opuviz Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF) inhibitor interchangeable biosimilar to Eylea indicated for the...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...